P3 Health Partners (PIII) Stock Price

P3 Health Partners Price

NASDAQ·CLOSED
5.47
​
Market closed

Over the last 7 years P3 Health Partners grew revenue by 49.4% annually, reaching 1.46 B USD. For P3 Health Partners, the net margin of -10.1% is down versus -6.4% a few years ago. The consensus 12-month price target for P3 Health Partners is 11.22 USD, about 105.1% above where the stock trades today. Of 9 analysts, 7 rate the stock a buy — an overall Buy consensus.

P3 Health Partners stock price

Access this data via the Eulerpool API

P3 Health Partners business model & stock analysis

P3 Health Partners, Inc. is a population health care management company, which engages in the provision of professional support services to doctors and clinicians. The company is headquartered in Chicago, Illinois and currently employs 600 full-time employees. The company went IPO on 2021-02-10. The firm transforms healthcare by improving the lives of both patients and providers led by physicians. The firm has an expansive network of approximately 2,800 affiliated primary care providers across the country. The firm supports primary care providers with value-based care coordination and administrative services that improve patient outcomes and lower costs. Through partnerships with these local providers, the Company creates an enhanced patient experience by navigating, coordinating, and integrating the patient’s care within the healthcare system. The firm serves Arizona, Nevada, Florida, Oregon, California, and more. The firm offers P3 care model that consists of education, tools, and support to manage illness, prevention and wellness support, medication management, nursing support, access to community resources and services, and transition of care teams.

Frequently asked questions about P3 Health Partners

Analysts currently set an average price target of 10.71 USD for the P3 Health Partners stock (median: 11.22 USD), implying +95.8 % versus the latest price. The consensus is based on 9 analyst ratings.

8 analysts currently rate the P3 Health Partners stock: 6 recommend buying, 2 holding and 0 selling. For 2026, analysts expect P3 Health Partners to generate revenue of 1.55 B USD and earnings per share of -32.61 USD.

Converted at the current exchange rate, the P3 Health Partners share trades at 4.88 EUR (5.47 USD).

The P3 Health Partners share (PIII) is listed on 1 stock exchanges, including: NASDAQ (PIII).

The expected revenue of P3 Health Partners is 1.55 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of P3 Health Partners is -107.00 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of P3 Health Partners is currently -0.17. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the P3 Health Partners stock.

The price-to-sales ratio (P/S) of P3 Health Partners is currently 0.01. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the P3 Health Partners stock.

The Eulerpool Quality Score for P3 Health Partners is 3/10.

The ISIN of P3 Health Partners is US7444132044. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of P3 Health Partners is PIII. The ticker symbol is used to trade P3 Health Partners shares on the stock exchange.

Fair ValueTerminal
5.58 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
2.43 M USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website ir.p3hp.org
Currency
USD
Initial public offering
Feb 10, 2021
ISIN
US7444132044
Cusip
744413105
Market capitalization
39.44 M USDMicro Cap
52-Week Range
PEG
0.00
P/E ratio
P/Ee 2026
-0.17
P/Ee 2027
-0.18
P/Ee 2028
-0.47
P/S
P/Se
0.01
EV/EBIT
—
P/B Ratio
0.52
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-114.11 %
Last updated Oct 9, 2026, 8:35 PM

P3 Health Partners Peer Group

P3 Health Partners Ticker

NASDAQ · PIII